Trial Profile
Randomized, Double-Blind, Multi-Center, Phase 3 Trial to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Hydrochlorothiazide Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients Not Controlled by Telmisartan/Amlodipine Combination
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Jan 2018
Price :
$35
*
At a glance
- Drugs Amlodipine/telmisartan/hydrochlorothiazide (Primary) ; Amlodipine/telmisartan
- Indications Essential hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Ildong Pharmaceutical
- 13 Dec 2017 Primary endpoint (The change of sitting systolic blood pressure) has been met, according to the results published in the Clinical Therapeutics
- 13 Dec 2017 Results published in the Clinical Therapeutics
- 23 Nov 2016 Status changed from recruiting to completed.